GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Zhejiang Chemsyn Pharm Co Ltd (BJSE:870656) » Definitions » Research & Development

Zhejiang Chemsyn Pharm Co (BJSE:870656) Research & Development : ¥8.5 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Zhejiang Chemsyn Pharm Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Zhejiang Chemsyn Pharm Co's Research & Development for the three months ended in Mar. 2024 was ¥2.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥8.5 Mil.

Zhejiang Chemsyn Pharm Co Research & Development Historical Data

The historical data trend for Zhejiang Chemsyn Pharm Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Chemsyn Pharm Co Research & Development Chart

Zhejiang Chemsyn Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.02 6.75 9.04 9.58 9.03

Zhejiang Chemsyn Pharm Co Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.44 2.51 2.13 1.95 1.96

Zhejiang Chemsyn Pharm Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥8.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Chemsyn Pharm Co  (BJSE:870656) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Zhejiang Chemsyn Pharm Co Research & Development Related Terms

Thank you for viewing the detailed overview of Zhejiang Chemsyn Pharm Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Chemsyn Pharm Co (BJSE:870656) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Zhejiang Chemsyn Pharm Co Ltd (BJSE:870656) » Definitions » Research & Development
Comparable Companies
Traded in Other Exchanges
N/A
Address
Huayang Road, No. 36, High-tech Industrial Park, Zhejiang Province, Quzhou City, CHN
Website
http://www.zcpc.net
Zhejiang Chemsyn Pharm Co Ltd is engaged in research& development, production and sales of veterinary raw materials, pharmaceutical raw materials and intermediates. Its products category includes API, Sulfa API, Intermediates. It also includes N-Acetylsulfanilyl Chloride, Sulfanilamide, Sulfachloropyridazine Sodium, Sulfachloropyrazine Sodium.

Zhejiang Chemsyn Pharm Co (BJSE:870656) Headlines

No Headlines